摘要
目的分析体外膜肺氧合治疗急性爆发性心肌炎患者的临床效果。方法选取本院2017年2月—2018年10月收治的急性爆发性心肌炎患者,共计20例,给予20例急性爆发性心肌炎患者仅实施体外膜肺氧合技术方案进行治疗,观察和分析其治疗效果。结果急性爆发性心肌炎患者治疗后,脑尿钠肽(BNP)、肌酸激酶同工酶(CK-MB)及心肌肌钙蛋白I(cTnI)水平均比治疗前有所改善,差异具有统计学意义(P<0.05);且20例急性爆发性心肌炎患者撤机均成功,好转出院,已恢复正常生活。结论急性爆发性心肌炎患者通过采取体外膜肺氧合技术治疗后效果显著,有效降低临床病死率和改善预后。
Objective To analyze the clinical effect of extracorporeal membrane oxygenation in the treatment of acute fulminant myocarditis. Methods 20 patients with acute fulminant myocarditis admitted to the hospital from February 2017 to October 2018 were selected.20 patients with acute fulminant myocarditis were treated with extracorporeal membrane oxygenation only.The therapeutic effect was observed and analyzed.Results After treatment,the levels of brain natriuretic peptide (BNP),creatine kinase isozyme (CK-MB) and cardiac troponin I (cTnI) in patients with acute fulminant myocarditis were improved compared with those before treatment,and the difference was statistically significant (P < 0.05);And 20 patients with acute fulminant myocarditis were successfully weaned,improved and discharged,and had returned to normal life.Conclusion Extracorporeal membrane oxygenation is effective in treating acute fulminant myocarditis,which can effectively reduce the clinical mortality and improve the prognosis.
作者
张孝连
ZHANG Xiaolian(Department of Pediatrics,Dezhou Lingcheng District People's Hospita,Dezhou Shandong 253500,China)
出处
《中国继续医学教育》
2019年第28期114-116,共3页
China Continuing Medical Education
关键词
体外膜肺氧合
急性爆发性心肌炎
安全性
临床效果
脑尿钠肽
肌酸激酶同工酶
心肌肌钙蛋白I
extracorporeal membrane oxygenation
acute fulminant myocarditis
safety
Clinical effects
brain natriuretic peptide
creatine kinase isoenzymes
cardiac troponini